Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 1/2016

13.04.2016

Changes in left ventricular filling parameters following catheter ablation of atrial fibrillation

verfasst von: Joseph T. Krezowski, Brent D. Wilson, Christopher J. McGann, Nassir F. Marrouche, Nazem Akoum

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Atrial fibrillation (AF) is common in the setting of abnormal ventricular relaxation.
We evaluated the association between ventricular relaxation grade and atrial fibrosis and examined the change in left ventricular filling parameters following catheter ablation.

Methods and results

AF patients undergoing catheter ablation who had cardiac late gadolinium enhancement MRI (LGE-MRI) and echocardiographic examinations were included in the study. Left atrial (LA) tissue fibrosis and volume were quantified using LGE-MRI. Echocardiograms were performed at baseline and 3 months following catheter ablation to assess left ventricular (LV) filling. Two hundred and ninety three patients (60.8 % male) met the inclusion criteria. In patients in sinus rhythm at baseline (n = 115), ventricular relaxation pattern was identified as normal in 54 patients (47.0 %), impaired in 35 (30.4 %), pseudo-normal in 18 (15.7 %), and restrictive in 8 (7.0 %). Restrictive LV filling was associated with higher LA volume index (61.2 ± 30.5 vs 46.0 ± 18.5 ml/m2; p < 0.01) and LA fibrosis (21.8 ± 10.9 % vs 15.5 ± 9.4 %; p = 0.036) compared to non-restrictive filling. In patients in sinus rhythm on both pre- and post-ablation echocardiograms (n = 104), A waves decreased from 0.70 ± 0.23 at baseline to 0.60 ± 0.20 (p < 0.01) and E/E’ decreased from 9.6 ± 4.0 at baseline to 8.6 ± 3.5 (p = 0.03). Thirty-two patients (27.2 %) had an improvement, and 24 patients (23.1 %) had a worsening in diastolic grade. Clinical heart failure and diabetes were associated with worse diastolic grade post-ablation.

Conclusions

Restrictive LV filling is associated with higher LA fibrosis. A change in echocardiographic LV filling pattern was noted in over 50 % of patients post-ablation.
Literatur
1.
Zurück zum Zitat Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., et al. (2011). ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Journal of the American College of Cardiology, 57(11), e101–98.CrossRefPubMed Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., et al. (2011). ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Journal of the American College of Cardiology, 57(11), e101–98.CrossRefPubMed
2.
Zurück zum Zitat Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., et al. (2001). Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, the Journal of the American Medical Association, 285(18), 2370–5.CrossRefPubMed Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., et al. (2001). Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, the Journal of the American Medical Association, 285(18), 2370–5.CrossRefPubMed
3.
Zurück zum Zitat Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006). Trends in prevalence and outcome of heart failure with preserved ejection fraction. The New England Journal of Medicine, 355(3), 251–9.CrossRefPubMed Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006). Trends in prevalence and outcome of heart failure with preserved ejection fraction. The New England Journal of Medicine, 355(3), 251–9.CrossRefPubMed
4.
Zurück zum Zitat Tsang, T. S., Gersh, B. J., Appleton, C. P., Tajik, A. J., Barnes, M. E., Bailey, K. R., et al. (2002). Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. Journal of the American College of Cardiology, 40(9), 1636–44.CrossRefPubMed Tsang, T. S., Gersh, B. J., Appleton, C. P., Tajik, A. J., Barnes, M. E., Bailey, K. R., et al. (2002). Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. Journal of the American College of Cardiology, 40(9), 1636–44.CrossRefPubMed
5.
Zurück zum Zitat Tokushima, T., Reid, C. L., & Gardin, J. M. (2001). Left ventricular diastolic function in the elderly. The American Journal of Geriatric Cardiology, 10(1), 20–9.CrossRefPubMed Tokushima, T., Reid, C. L., & Gardin, J. M. (2001). Left ventricular diastolic function in the elderly. The American Journal of Geriatric Cardiology, 10(1), 20–9.CrossRefPubMed
6.
Zurück zum Zitat Lee, D. S., Gona, P., Vasan, R. S., Larson, M. G., Benjamin, E. J., Wang, T. J., et al. (2009). Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation, 119(24), 3070–7.CrossRefPubMedPubMedCentral Lee, D. S., Gona, P., Vasan, R. S., Larson, M. G., Benjamin, E. J., Wang, T. J., et al. (2009). Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation, 119(24), 3070–7.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Rosenberg, M. A., Gottdiener, J. S., Heckbert, S. R., & Mukamal, K. J. (2012). Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study. European Heart Journal, 33(7), 904–12.CrossRefPubMed Rosenberg, M. A., Gottdiener, J. S., Heckbert, S. R., & Mukamal, K. J. (2012). Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study. European Heart Journal, 33(7), 904–12.CrossRefPubMed
8.
Zurück zum Zitat Allessie, M., Ausma, J., & Schotten, U. (2002). Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovascular Research, 54(2), 230–46.CrossRefPubMed Allessie, M., Ausma, J., & Schotten, U. (2002). Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovascular Research, 54(2), 230–46.CrossRefPubMed
9.
Zurück zum Zitat Bosch, R. F., Zeng, X., Grammer, J. B., Popovic, K., Mewis, C., & Kühlkamp, V. (1999). Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovascular Research, 44(1), 121–31.CrossRefPubMed Bosch, R. F., Zeng, X., Grammer, J. B., Popovic, K., Mewis, C., & Kühlkamp, V. (1999). Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovascular Research, 44(1), 121–31.CrossRefPubMed
10.
Zurück zum Zitat Casaclang-Verzosa, G., Gersh, B. J., & Tsang, T. S. (2008). Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. Journal of the American College of Cardiology, 51(1), 1–11.CrossRefPubMed Casaclang-Verzosa, G., Gersh, B. J., & Tsang, T. S. (2008). Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. Journal of the American College of Cardiology, 51(1), 1–11.CrossRefPubMed
11.
Zurück zum Zitat Pappone, C., Rosanio, S., Oreto, G., Tocchi, M., Gugliotta, F., Vicedomini, G., et al. (2000). Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation, 102(21), 2619–28.CrossRefPubMed Pappone, C., Rosanio, S., Oreto, G., Tocchi, M., Gugliotta, F., Vicedomini, G., et al. (2000). Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation, 102(21), 2619–28.CrossRefPubMed
12.
Zurück zum Zitat Marrouche, N. F., Dresing, T., Cole, C., Bash, D., Saad, E., Balaban, K., et al. (2002). Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. Journal of the American College of Cardiology, 40(3), 464–74.CrossRefPubMed Marrouche, N. F., Dresing, T., Cole, C., Bash, D., Saad, E., Balaban, K., et al. (2002). Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. Journal of the American College of Cardiology, 40(3), 464–74.CrossRefPubMed
13.
Zurück zum Zitat Oakes, R. S., Badger, T. J., Kholmovski, E. G., Akoum, N., Burgon, N. S., Fish, E. N., et al. (2009). Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation, 119(13), 1758–67.CrossRefPubMedPubMedCentral Oakes, R. S., Badger, T. J., Kholmovski, E. G., Akoum, N., Burgon, N. S., Fish, E. N., et al. (2009). Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation, 119(13), 1758–67.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Akoum, N., Daccarett, M., McGann, C., Segerson, N., Vergara, G., Kuppahally, S., et al. (2011). Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. Journal of Cardiovascular Electrophysiology, 22(1), 16–22.CrossRefPubMed Akoum, N., Daccarett, M., McGann, C., Segerson, N., Vergara, G., Kuppahally, S., et al. (2011). Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. Journal of Cardiovascular Electrophysiology, 22(1), 16–22.CrossRefPubMed
15.
Zurück zum Zitat McGann C, Akoum N, Patel A, Kholmovski E, Revelo P, Damal K, et al. Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circulation Arrhythmia and electrophysiology. 2013. McGann C, Akoum N, Patel A, Kholmovski E, Revelo P, Damal K, et al. Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circulation Arrhythmia and electrophysiology. 2013.
16.
Zurück zum Zitat Khan, M. N., Jais, P., Cummings, J., Di Biase, L., Sanders, P., Martin, D. O., et al. (2008). Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. The New England Journal of Medicine, 359(17), 1778–85.CrossRefPubMed Khan, M. N., Jais, P., Cummings, J., Di Biase, L., Sanders, P., Martin, D. O., et al. (2008). Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. The New England Journal of Medicine, 359(17), 1778–85.CrossRefPubMed
17.
Zurück zum Zitat Hsu, L. F., Jais, P., Sanders, P., Garrigue, S., Hocini, M., Sacher, F., et al. (2004). Catheter ablation for atrial fibrillation in congestive heart failure. The New England Journal of Medicine, 351(23), 2373–83.CrossRefPubMed Hsu, L. F., Jais, P., Sanders, P., Garrigue, S., Hocini, M., Sacher, F., et al. (2004). Catheter ablation for atrial fibrillation in congestive heart failure. The New England Journal of Medicine, 351(23), 2373–83.CrossRefPubMed
18.
Zurück zum Zitat Cha, Y. M., Wokhlu, A., Asirvatham, S. J., Shen, W. K., Friedman, P. A., Munger, T. M., et al. (2011). Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function. Circulation. Arrhythmia and Electrophysiology, 4(5), 724–32.CrossRefPubMed Cha, Y. M., Wokhlu, A., Asirvatham, S. J., Shen, W. K., Friedman, P. A., Munger, T. M., et al. (2011). Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function. Circulation. Arrhythmia and Electrophysiology, 4(5), 724–32.CrossRefPubMed
19.
Zurück zum Zitat Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., et al. (2009). Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Journal of the American Society of Echocardiography, 22(2), 107–33.CrossRefPubMed Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., et al. (2009). Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Journal of the American Society of Echocardiography, 22(2), 107–33.CrossRefPubMed
20.
Zurück zum Zitat Maisel, W. H., & Stevenson, L. W. (2003). Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. The American Journal of Cardiology, 91(6A), 2D–8D.CrossRefPubMed Maisel, W. H., & Stevenson, L. W. (2003). Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. The American Journal of Cardiology, 91(6A), 2D–8D.CrossRefPubMed
21.
Zurück zum Zitat Benjamin, E. J., Levy, D., Vaziri, S. M., D’Agostino, R. B., Belanger, A. J., & Wolf, P. A. (1994). Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA : The Journal of the American Medical Association, 271(11), 840–4.CrossRefPubMed Benjamin, E. J., Levy, D., Vaziri, S. M., D’Agostino, R. B., Belanger, A. J., & Wolf, P. A. (1994). Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA : The Journal of the American Medical Association, 271(11), 840–4.CrossRefPubMed
22.
Zurück zum Zitat Zakeri, R., Chamberlain, A. M., Roger, V. L., & Redfield, M. M. (2013). Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. Circulation, 128(10), 1085–93.CrossRefPubMedPubMedCentral Zakeri, R., Chamberlain, A. M., Roger, V. L., & Redfield, M. M. (2013). Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. Circulation, 128(10), 1085–93.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Hogg, K., Swedberg, K., & McMurray, J. (2004). Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. Journal of the American College of Cardiology, 43(3), 317–27.CrossRefPubMed Hogg, K., Swedberg, K., & McMurray, J. (2004). Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. Journal of the American College of Cardiology, 43(3), 317–27.CrossRefPubMed
24.
Zurück zum Zitat McMurray, J. J., Carson, P. E., Komajda, M., McKelvie, R., Zile, M. R., Ptaszynska, A., et al. (2008). Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. European Journal of Heart Failure, 10(2), 149–56.CrossRefPubMed McMurray, J. J., Carson, P. E., Komajda, M., McKelvie, R., Zile, M. R., Ptaszynska, A., et al. (2008). Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. European Journal of Heart Failure, 10(2), 149–56.CrossRefPubMed
25.
Zurück zum Zitat Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S. A., et al. (2012). HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm : the Official Journal of the Heart Rhythm Society, 9(4), 632–96 e21.CrossRef Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S. A., et al. (2012). HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm : the Official Journal of the Heart Rhythm Society, 9(4), 632–96 e21.CrossRef
26.
Zurück zum Zitat Medi, C., Kalman, J. M., Spence, S. J., Teh, A. W., Lee, G., Bader, I., et al. (2011). Atrial electrical and structural changes associated with longstanding hypertension in humans: implications for the substrate for atrial fibrillation. Journal of Cardiovascular Electrophysiology, 22(12), 1317–24.CrossRefPubMed Medi, C., Kalman, J. M., Spence, S. J., Teh, A. W., Lee, G., Bader, I., et al. (2011). Atrial electrical and structural changes associated with longstanding hypertension in humans: implications for the substrate for atrial fibrillation. Journal of Cardiovascular Electrophysiology, 22(12), 1317–24.CrossRefPubMed
27.
Zurück zum Zitat De Jong, A. M., Van Gelder, I. C., Vreeswijk-Baudoin, I., Cannon, M. V., Van Gilst, W. H., & Maass, A. H. (2013). Atrial remodeling is directly related to end-diastolic left ventricular pressure in a mouse model of ventricular pressure overload. PloS One, 8(9), e72651.CrossRefPubMedPubMedCentral De Jong, A. M., Van Gelder, I. C., Vreeswijk-Baudoin, I., Cannon, M. V., Van Gilst, W. H., & Maass, A. H. (2013). Atrial remodeling is directly related to end-diastolic left ventricular pressure in a mouse model of ventricular pressure overload. PloS One, 8(9), e72651.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Thomas, L., Thomas, S. P., Hoy, M., Boyd, A., Schiller, N. B., & Ross, D. L. (2004). Comparison of left atrial volume and function after linear ablation and after cardioversion for chronic atrial fibrillation. The American Journal of Cardiology, 93(2), 165–70.CrossRefPubMed Thomas, L., Thomas, S. P., Hoy, M., Boyd, A., Schiller, N. B., & Ross, D. L. (2004). Comparison of left atrial volume and function after linear ablation and after cardioversion for chronic atrial fibrillation. The American Journal of Cardiology, 93(2), 165–70.CrossRefPubMed
29.
Zurück zum Zitat Thomas, L., Boyd, A., Thomas, S. P., Schiller, N. B., & Ross, D. L. (2003). Atrial structural remodelling and restoration of atrial contraction after linear ablation for atrial fibrillation. European Heart Journal, 24(21), 1942–51.CrossRefPubMed Thomas, L., Boyd, A., Thomas, S. P., Schiller, N. B., & Ross, D. L. (2003). Atrial structural remodelling and restoration of atrial contraction after linear ablation for atrial fibrillation. European Heart Journal, 24(21), 1942–51.CrossRefPubMed
Metadaten
Titel
Changes in left ventricular filling parameters following catheter ablation of atrial fibrillation
verfasst von
Joseph T. Krezowski
Brent D. Wilson
Christopher J. McGann
Nassir F. Marrouche
Nazem Akoum
Publikationsdatum
13.04.2016
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 1/2016
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-016-0131-8

Weitere Artikel der Ausgabe 1/2016

Journal of Interventional Cardiac Electrophysiology 1/2016 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.